Product Information
DICLOFENAC 0.1% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $1.6954 per ML under NDC 24208045705. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 28, 2007. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Diclofenac Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208045705
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
DICLOFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA078792FDA Approved
12/28/2007
TE Code
AT
On Market Since
12/28/2007
Pharmacological Classes
Price Statistics
The NADAC for DICLOFENAC 0.1% EYE DROPS has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 10.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.6954 per ML |
|---|---|
| All-time high | $6.6158 (Aug 15, 2018) |
| All-time low | $1.1957 (Jul 22, 2020) |
| 52-week high | $2.0153 |
| 52-week low | $1.6954 |
| Median price | $1.7981 |
| Average price | $1.9247 |
| Largest weekly change | +136.6% (Mar 21, 2018) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diclofenac Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DICLOFENAC 0.1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for DICLOFENAC 0.1% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $1.6954 per ML (NDC 24208045705), effective Sep 30, 2026.
How has the price of DICLOFENAC 0.1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for DICLOFENAC 0.1% EYE DROPS has risen 10.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DICLOFENAC 0.1% EYE DROPS?
Since Nov 28, 2013, the NADAC for DICLOFENAC 0.1% EYE DROPS has ranged from a low of $1.1957 (Jul 22, 2020) to a high of $6.6158 (Aug 15, 2018), with a median of $1.7981 per ML.
Are there cheaper alternatives to DICLOFENAC 0.1% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DICLOFENAC 0.1% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures DICLOFENAC 0.1% EYE DROPS?
DICLOFENAC 0.1% EYE DROPS (NDC 24208045705) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.